European Heart Journal-Quality of Care and Clinical Outcomes

Papers
(The H4-Index of European Heart Journal-Quality of Care and Clinical Outcomes is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Ambulance drive-thru troponin, ready to go?79
Letter to the editor in response to Kobo et al. 202261
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor60
Evolving perspectives in personalized cardiovascular care58
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease51
Association of lipoprotein(a) level and major adverse cardiovascular events in adult cancer survivors with atherosclerotic disease35
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied35
Secundum atrial septal defect closure in adults in the UK32
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–2031
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events30
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease29
Heart failure with reduced ejection fraction: a systematic review of clinical practice guidelines and recommendations28
Beyond biomarkers: the relevance of supporting evidence in the diagnosis of periprocedural myocardial infarction28
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis26
Beyond the SMuRF-less paradox: disaggregation may restore clinical meaning25
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings22
Intracoronary imaging for percutaneous coronary intervention: worth the cost?21
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations21
Beyond weight loss in hypertrophic cardiomyopathy: metabolic therapy and the evolving treatment paradigm21
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study20
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings20
Mitral valve prolapse: incidence and prognosis related to serum levels of sex hormone-binding globulin20
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes20
0.042742013931274